TriSalus Life Sciences Announces First Patient Enrolled in PERIO-01 Clinical Trial to Evaluate Delivery of SD-101 via Pressure-Enabled Drug Delivery in Uveal Melanoma Liver Metastases
DENVER & CHICAGO--(BUSINESS WIRE)-- #cancer--TriSalus Life Sciences announces the first patient enrolled in the PERIO-01 clinical trial for adults with uveal melanoma liver metastases.